BY Nicholas Almanza

Testing for BRCA1 and BRCA2 seeks to identify mutations associated with increased risk of developing certain cancers over a person’s lifetime (primarily breast and ovarian cancers in women and breast and prostate cancers in men). Researchers suspect inherited mutations are associated with 5 to 10 percent of all cancers. National guidelines exist to determine which patients with cancer should receive an evaluation for hereditary cancer...

Dr. Karen Lu and genetic counselor Erica Bednar